![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Dr. Paul Lohmann Gmbh & Co. Kgaa Emmerthal De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Ferrous fumarate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2004-232 - Rev 03
This Chemical Type CEP, issued on July 13, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 902 associated with this CEP further emphasizes